Nationwide Fund Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,586
Closed -$514K 3076
2017
Q3
$514K Sell
15,586
-291
-2% -$10.1K ﹤0.01% 2172
2017
Q2
$531K Buy
15,877
+328
+2% +$9.79K ﹤0.01% 2155
2017
Q1
$450K Sell
15,549
-1,526
-9% -$37.8K ﹤0.01% 2210
2016
Q4
$382K Sell
17,075
-644
-4% -$12.6K ﹤0.01% 2321
2016
Q3
$329K Hold
17,719
﹤0.01% 2381
2016
Q2
$289K Buy
17,719
+601
+4% +$8.84K ﹤0.01% 2431
2016
Q1
$200K Sell
17,118
-1,170
-6% -$13.1K ﹤0.01% 2539
2015
Q4
$214K Hold
18,288
﹤0.01% 2518
2015
Q3
$224K Sell
18,288
-105
-0.6% -$1.34K ﹤0.01% 2506
2015
Q2
$173K Sell
18,393
-1,348
-7% -$12.5K ﹤0.01% 2783
2015
Q1
$175K Sell
19,741
-846
-4% -$8.55K ﹤0.01% 2760
2014
Q4
$206K Sell
20,587
-5,614
-21% -$48.1K ﹤0.01% 2620
2014
Q3
$176K Buy
26,201
+418
+2% +$2.93K ﹤0.01% 2758
2014
Q2
$185K Buy
+25,783
New +$205K ﹤0.01% 2790
2014
Q1
Sell
-7,210
Closed -$57K 3337
2013
Q4
$57K Hold
7,210
﹤0.01% 3057
2013
Q3
$71K Buy
7,210
+5,700
+377% +$44.9K ﹤0.01% 3009
2013
Q2
$9K Buy
+1,510
New +$5.08K ﹤0.01% 3136

Other funds holding BEAT

Nationwide Fund Advisors's BEAT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 15,586 shares — an estimated $514K sold.

Nationwide Fund Advisors first reported a position in BEAT in Q2 2013 and held it in 17 quarters. The position peaked at $531K in Q2 2017. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 15,586 BioTelemetry, Inc. shares in Q4 2017, an estimated $514K.
  • Nationwide Fund Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's BioTelemetry, Inc. position peaked at $531K in Q2 2017.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.